Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Gilead Sciences Inc. published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 27
» View wsbt.com items only
    May 17, 2013 |Story| Reuters
  1. U.S. RESEARCH ROUNDUP: Visa, Wal-Mart, Biogen Idec, Walt Disney

    Reuters
    May 17 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Macy's and Biogen Idec on Friday. HIGHLIGHTS * Aruba Networks : FBN, JP Morgan, Needham, Wedbush, Wells Fargo cut rating *...

    Tags: Tesla Motors, Inc., Applied Materials Incorporated, Verizon Communications, Leap Wireless International Incorporated, The Home Depot

  2. May 15, 2013 |Story| Reuters
  3. Experimental Gilead drug effective in early-stage leukemia trial

    Reuters
    By Deena Beasley May 15 (Reuters) - An experimental drug from Gilead Sciences Inc shrank tumors in half of leukemia patients whose cancer had returned, according to an early-stage trial that represents a new foray into oncology by the world's biggest...

    Tags: Symptoms, Health Treatments, Diseases and Illnesses, Medical Research, Chemical Industry

  4. May 15, 2013 |Story| Reuters
  5. TAKE A LOOK-New cancer data highlights immunotherapies, leukemia drugs

    Reuters
    Bristol-Myers' promising new combination of treatments to fight melanoma by harnessing the body's immune system and a foray into treating leukemia and other blood cancers by HIV-drug giant Gilead Sciences Inc are among the highlights of early results...

    Tags: HIV, Leukemia, Chemotherapy, Skin Cancer

  6. May 13, 2013 |Story| Reuters
  7. U.S. RESEARCH ROUNDUP: AIG, Express Scripts, Eli Lilly, Carlyle Group

    Reuters
    May 13 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including AIG, Carlyle Group and Express Scripts, on Monday. HIGHLIGHTS * AIG : Barclays raises to overweight from equal weight -...

    Tags: Theravance Incorporated, Range Resources Corporation, Energy Partners Limited, Nelnet Incorporated, Liberty Media Corporation

  8. May 8, 2013 |Story| Reuters
  9. Many in U.S. don't get proper testing for hepatitis C- CDC

    Reuters
    By Julie Steenhuysen NEW YORK, May 8 (Reuters) - Only half of people in the United States who have ever been infected with hepatitis C get proper testing for the liver-destroying disease, according to U.S. health officials. Proper testing is a two-...

    Tags: Merck & Company Incorporated, Viral Diseases and Infections, Hepatitis, Medical Research, Diseases and Illnesses

  10. May 7, 2013 |Story| Reuters
  11. REUTERS SUMMIT-Biotech firms evolve from targets to acquirers

    Reuters
    (For other news from Reuters Health Summit, click on http://www.reuters.com/summit/Health13) * Skyrocketing valuations quash talks * With financing available, many biotechs go it alone * Bankers expect steady flow of $1 bln to $5 bln pharma deals By...

    Tags: Banking, Celgene Corporation, Technology, Business Enterprises, Chemical Industry

  12. May 3, 2013 |Story| Reuters
  13. U.S. RESEARCH ROUNDUP: Estee Lauder, Actavis, MGM Resorts

    Reuters
    May 3 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Estee Lauder and MGM Resorts, on Friday. HIGHLIGHTS * LinkedIn Corp : BMO, JP Morgan, Canaccord Genuity, others raise...

    Tags: Ameren Corporation, Alpha Natural Resources Incorporated, BB&T Corp., Weatherford International Incorporated, Ubiquiti Networks, Inc.

  14. May 2, 2013 |Story| Reuters
  15. CORRECTED-Gilead profit rises 63 pct, sales of older HIV drugs dip

    Reuters
    (Corrects 3rd paragraph to show Complera sales rose 184 percent, not 10 percent; shows that sales of Stribild totaled $92.1 million, with no prior year comparison, not that they rose 184 percent) May 2 (Reuters) - Gilead Sciences Inc said on Thursday its...

    Tags: HIV, Earnings Forecasts, New Products, Truvada, Thomson Corporation

  16. May 2, 2013 |Story| Reuters
  17. U.S. RESEARCH ROUNDUP: MasterCard, Visa, Facebook, Las Vegas Sands

    Reuters
    May 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Visa and Facebook, on Thursday. HIGHLIGHTS * MasterCard Inc : Nomura cuts target price to $593 from $611; rating buy * DXP...

    Tags: Renewable Energy, Pinnacle Entertainment Incorporated, Viacom Inc., NII Holdings Incorporated, Energizer Holdings Incorporated

  18. May 2, 2013 |Story| Reuters
  19. US STOCKS SNAPSHOT-Nasdaq up 1 pct as Wall St extends advance

    Reuters
    NEW YORK, May 2 (Reuters) - U.S. stocks extended their advance on Thursday, with the Nasdaq Composite up 1 percent, led by gains in shares of Apple and Gilead Sciences. The Dow Jones industrial average rose 113.46 points or 0.77 percent, to 14,814.41,...

    Tags: Nasdaq Composite, NASDAQ, Stock Activities, European Central Bank, Financial Markets

  20. Apr 29, 2013 |Story| Reuters
  21. U.S. RESEARCH ROUNDUP: 3M, Time Warner, Walt Disney, Caterpillar

    Reuters
    April 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S. companies, including Time Warner, 3M Co and Caterpillar, on Monday. HIGHLIGHTS * 3M Co : JP Morgan cuts target price to $95 from $97; rating...

    Tags: Cerner Corp., Range Resources Corporation, Parker Hannifin Corporation, NII Holdings Incorporated, Viacom Inc.

  22. Apr 23, 2013 |Story| Reuters
  23. AbbVie says drug cocktail wipes out hepatitis C in 8 weeks

    AbbVie Inc. said tests show its five-drug cocktail known as Aviator wipes out the hepatitis C virus in 96 percent of patients who take it for 12 weeks -- less than half the time of current treatments, according to researchers.
    Reuters
    AbbVie Inc. said tests show its five-drug cocktail known as Aviator wipes out the hepatitis C virus in 96 percent of patients who take it for 12 weeks -- less than half the time of current treatments, according to researchers. At least 88 percent of new...

    Tags: Viral Diseases and Infections, Science and Technology, Medical Research, Insomnia, NYSE Euronext, Inc.

 1  2 3Next >
Original site for Gilead Sciences Inc. topic gallery.